Jessica L. Taylor, MD

Assistant Professor, Medicine

Jessica Taylor
617.414.7399
801 Massachusetts Ave Crosstown Center

Biography

Jessica L. Taylor, MD is an Assistant Professor of Medicine in General Internal Medicine at the Boston University School of Medicine and Boston Medical Center and a board-certified Addiction Specialist. She attended Mount Sinai School of Medicine and completed her internal medicine residency at Beth Israel Deaconess Medical Center and Harvard Medical School, where also served as a Chief Resident. She joined BUSM faculty in 2016. Dr. Taylor’s clinical work focuses on the care of patients with substance use disorders, HIV, and viral hepatitis. Her research interests include HIV prevention among people who inject drugs, implementation strategies for HIV pre-exposure prophylaxis (PrEP), low-barrier substance use disorder treatment models, and overdose prevention.

Dr. Taylor is the Medical Director of Faster Paths to Treatment, Boston Medical Center’s innovative, low-barrier substance use disorder bridge clinic. She also directs HIV Prevention Programs at BMC and is a past Medical Director of BMC’s Office Based Addiction Treatment (OBAT) ECHO, a tele-education series for providers and teams across MA. Her other educational roles include co-directing the HIV Pathway for internal medicine residents and serving as core faculty in BUSM’s Addiction Medicine fellowship program.

Other Positions

  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine

Education

  • Mount Sinai School of Medicine, MD
  • Duke University, BS

Publications

  • Published on 2/7/2022

    Alves J, Stewart J, Ruiz-Mercado G, Taylor JL. When Perfect Is the Enemy of Tested: a Call to Scale Rapid HIV Testing for People Who Inject Drugs. J Gen Intern Med. 2022 Feb 07. PMID: 35132547.

    Read at: PubMed
  • Published on 1/11/2022

    Taylor JL, Samet JH. Opioid Use Disorder. Ann Intern Med. 2022 01; 175(1):ITC1-ITC16. PMID: 35007147.

    Read at: PubMed
  • Published on 1/1/2022

    Bonner R, Stewart J, Upadhyay A, Bruce RD, Taylor JL. A Primary Care Intervention to Increase HIV Pre-Exposure Prophylaxis (PrEP) Uptake in Patients with Syphilis. J Int Assoc Provid AIDS Care. 2022 Jan-Dec; 21:23259582211073393. PMID: 35001723.

    Read at: PubMed
  • Published on 12/28/2021

    Laks J, Kehoe J, Farrell NM, Komaromy M, Kolodziej J, Walley AY, Taylor JL. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule. Addict Sci Clin Pract. 2021 12 28; 16(1):73. PMID: 34961554.

    Read at: PubMed
  • Published on 11/1/2021

    Harvey L, Taylor JL, Assoumou SA, Kehoe J, Schechter-Perkins EM, Bernstein E, Walley AY. Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic. J Addict Med. 2021 Nov-Dec 01; 15(6):461-467. PMID: 34734572.

    Read at: PubMed
  • Published on 11/1/2021

    Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01; 15(6):448-451. PMID: 33298750.

    Read at: PubMed
  • Published on 6/22/2021

    Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment. J Gen Intern Med. 2021 12; 36(12):3810-3819. PMID: 34159545.

    Read at: PubMed
  • Published on 6/3/2021

    Brody JK, Taylor J, Biello K, Bazzi AR. Towards equity for people who inject drugs in HIV prevention drug trials. Int J Drug Policy. 2021 10; 96:103284. PMID: 34092469.

    Read at: PubMed
  • Published on 4/27/2021

    Burns RH, Pierre CM, Marathe JG, Ruiz-Mercado G, Taylor JL, Kimmel SD, Johnson SL, Fukuda HD, Assoumou SA. Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. Open Forum Infect Dis. 2021 Aug; 8(8):ofab208. PMID: 34409120.

    Read at: PubMed
  • Published on 3/22/2021

    Assoumou SA, Paniagua SM, Gonzalez P, Wang J, Beckwith CG, White LF, Taylor JL, Coogan K, Samet JH, Linas BP. HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges. AIDS Behav. 2021 Aug; 25(8):2591-2598. PMID: 33751315.

    Read at: PubMed

View 13 more publications: View full profile at BUMC

View all profiles